Your search returned 5 results.

Results
	1.	Diabetes market grows ever more crowded. [electronic resource] by Gohil, Kunj Enhoffer, Devin Producer: 20141217 In: P & T : a peer-reviewed journal for formulary management vol. 39 Availability: No items available. Save to lists Add to cart (remove)
	2.	Modest growth seen in epilepsy market. [electronic resource] by Gohil, Kunj Enhoffer, Devin Producer: 20141114 In: P & T : a peer-reviewed journal for formulary management vol. 39 Availability: No items available. Save to lists Add to cart (remove)
	3.	Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials enrollment criteria to the US type 2 diabetes population. [electronic resource] by Wittbrodt, Eric T Eudicone, James M Bell, Kelly F Enhoffer, Devin M Latham, Keith Green, Jennifer B Producer: 20191125 In: The American journal of managed care vol. 24 Availability: No items available. Save to lists Add to cart (remove)
	4.	Eligibility varies among the 4 sodium-glucose cotransporter-2 inhibitor cardiovascular outcomes trials: implications for the general type 2 diabetes US population. [electronic resource] by Wittbrodt, Eric T Eudicone, James M Bell, Kelly F Enhoffer, Devin M Latham, Keith Green, Jennifer B Producer: 20191125 In: The American journal of managed care vol. 24 Availability: No items available. Save to lists Add to cart (remove)
	5.	Authors' reply to "Comment on generalizability of GLP-1 RA CVOTs in US T2D population". [electronic resource] by Wittbrodt, Eric T Eudicone, James M Bell, Kelly F Enhoffer, Devin M Latham, Keith Green, Jennifer B Producer: 20191209 In: The American journal of managed care vol. 25 Availability: No items available. Save to lists Add to cart (remove)